Asset Management
Truist Financial reduced its price target for Charles Schwab from $130 to $125 in a research note issued Tuesday, according to MarketBeat, citing Benzinga. The brokerage maintained its Buy rating, indicating that its overall assessment remained positive despite the lower target.
Based on the referenced closing price of $97.08, Truist’s revised target implied potential upside of approximately 28.76%. The adjustment represents a more conservative valuation estimate than the previous target, but it does not necessarily indicate a change in the firm’s broader view of Schwab’s business prospects.
Other analysts have issued varying assessments. Citigroup reiterated a Market Outperform rating, Compass Point initiated coverage with a Buy rating and a $135 target, and Raymond James maintained an Outperform rating with a $145 target. Deutsche Bank also raised its price target from $125 to $130. In contrast, Bank of America increased its target from $91 to $95 while retaining an Underperform rating, and Evercore initiated coverage with an In Line rating and a $107 target.
MarketBeat reported a consensus Moderate Buy rating, comprising one Strong Buy, 16 Buy, five Hold, and one Sell recommendation. The average price target was $119. These estimates illustrate differences in analysts’ expectations for Schwab’s earnings outlook and valuation.
Charles Schwab’s latest reported quarterly results exceeded analyst expectations. The company recorded earnings per share of $1.62, compared with the consensus estimate of $1.56. Revenue reached $7.07 billion, above the expected $6.90 billion and 20.9% higher than in the corresponding period a year earlier.
The company reported a return on equity of 24.53% and a net margin of 38.79%. Analysts cited in the report expected full-year earnings per share of approximately $6.46.
The results indicate strong reported revenue growth and profitability for the quarter. However, investors will need to assess whether those trends can continue as market activity, interest-rate conditions, and operating expenses evolve.
Charles Schwab shares opened at $97.08 in the session described in the report. The stock’s 50-day simple moving average stood at $105.50, while its 200-day moving average was $98.15. Its reported 52-week range extended from $83.96 to $114.53.
The company had a market capitalization of approximately $167.88 billion and a price-to-earnings ratio of 17.65. Its price-to-earnings-growth ratio was 0.82, and its beta was 0.79.
These metrics provide context for Schwab’s market valuation and trading history, but they do not independently establish whether the shares are undervalued. Investors must also consider the sustainability of earnings, interest-rate sensitivity, operating costs, and the outlook for client assets and trading activity.
MarketBeat reported that company insiders sold 645,582 shares valued at approximately $69.55 million during the preceding quarter. Insider Dennis Howard sold 28,000 shares under a pre-arranged Rule 10b5-1 trading plan, while director Paula A. Sneed also reported a share sale.
Insider transactions can provide context about changes in ownership, but planned sales do not automatically indicate a negative view of a company’s prospects. The circumstances and timing of each transaction remain relevant to interpretation.
Institutional investors and hedge funds owned approximately 84.38% of Schwab’s shares, according to the report. Invesco, Bank of New York Mellon, and Bank of America were among the institutions reported to hold substantial positions. Institutional ownership reflects the composition of the shareholder base but does not guarantee future share-price performance.
Schwab’s next earnings report, identified in the supplied material as scheduled for October 15, is expected to draw attention to its principal revenue sources. Net interest revenue, asset-management fees, and trading-related income could benefit from favorable market activity and interest-rate conditions.
Deutsche Bank’s higher price target and Erste Group Bank’s increased fiscal 2027 earnings estimate provide additional evidence of positive expectations among some analysts. Erste raised its 2027 EPS estimate to $7.96 from $7.85, above the cited current-year consensus estimate of $6.46.
Operating expenses remain a key risk. If costs increase faster than revenue, they could limit the benefit of stronger trading activity, net interest revenue, and asset-management fees. Investors will therefore be watching both quarterly results and management’s guidance for the coming periods.
Truist’s decision to lower its price target while maintaining a Buy rating reflects a more cautious valuation assessment without reversing its positive stance on Charles Schwab. The company’s latest reported earnings beat and revenue growth provide a constructive operating backdrop, while the broader analyst consensus remains moderately positive.
Nevertheless, price targets vary considerably, insider sales require context, and future performance will depend on the sustainability of earnings growth. Schwab’s upcoming results should provide further information about its revenue drivers, cost structure, and ability to maintain profitability under changing market conditions.
For a confidential discussion about wealth strategy, financial risk, or cross-border financial planning, contact the SKN CBBA advisory team.
October 12, 2026
September 29, 2026
September 7, 2026
September 4, 2026
Optimized by Seraphinite Accelerator
